Alpha Tau to Participate in May Investor Conferences
Provided By GlobeNewswire
Last update: May 6, 2025
JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will presentation in the following investor conferences in May 2025.
Read more at globenewswire.comNASDAQ:DRTS (6/3/2025, 9:57:50 AM)
2.92
-0.01 (-0.34%)
NASDAQ:DRTSW (5/30/2025, 8:00:01 PM)
0.21
-0.04 (-16%)
Find more stocks in the Stock Screener
